History
  • No items yet
midpage
State v. Actavis Pharma, Inc. & a.
167 A.3d 1277
| N.H. | 2017
Read the full case

Background

  • In June and September 2015 the New Hampshire Attorney General’s Office (OAG) retained Cohen Milstein on a contingency-fee basis to assist in investigating and potentially litigating claims about fraudulent marketing of opioid drugs.
  • In August 2015 the OAG issued administrative subpoenas under the Consumer Protection Act (RSA ch. 358-A) to several opioid manufacturers requesting documents about sales, marketing, and prescribing.
  • Defendants initially agreed to comply but then refused, objecting that the OAG’s contingency-fee retention of Cohen Milstein was unlawful and created conflicts of interest.
  • The OAG moved to enforce the subpoenas; defendants counterclaimed and sought a protective order declaring the contingency-fee agreement void and barring Cohen Milstein’s participation.
  • The superior court granted the protective order, held the contingency-fee agreement ultra vires for failing to obtain required approvals, but rejected defendants’ Ethics Code and due process claims.
  • The State appealed the standing ruling; defendants cross-appealed the Ethics Code and due process determinations. The Supreme Court reversed on standing and other grounds and remanded.

Issues

Issue State's Argument Defendants' Argument Held
Do defendants have standing to challenge the OAG’s contingency-fee contract as ultra vires under RSA 7:12 and RSA 7:6-f? Defendants lack standing because they failed to show actual, traceable harm from the OAG’s alleged failure to obtain approvals. The contingency fee taints the investigation and creates a conflict of interest that personally injures subpoenaed defendants. No standing: defendants failed to show their alleged bias injury was traceable to the statutory approval defect or that RSA 7:6-f injury was actual or imminent.
Does the Executive Branch Code of Ethics (RSA 21-G:21–27) create a private right of action for defendants to sue? (State) Ethics Code does not create a private civil remedy; enforcement is for the ethics committee. (Defendants) Ethics Code violations support their challenge and provide a basis to enjoin Cohen Milstein. No private right of action under the Ethics Code; defendants lack standing to sue under it.
Does the contingency-fee agreement violate common-law or professional-ethics rules by making Cohen Milstein a public attorney or creating an impermissible conflict? (State) The agreement expressly leaves the OAG in control; Cohen Milstein is not a public attorney and has no independent authority. (Defendants) A private lawyer with a financial stake in outcomes cannot act for the State without compromising impartiality. Agreement preserves OAG control and key decision-making; Cohen Milstein is not a substitute public attorney, so no common-law or ethics violation on this record.
Does the contingency-fee arrangement violate due process by creating an impermissible risk of bias in enforcement? (State) OAG retained supervisory control, neutralizing any conflict; precedent does not categorically bar such arrangements in civil enforcement. (Defendants) Supreme Court precedent prohibits arrangements that risk undermining a government lawyer’s duty to seek justice over private gain. No reversible error: given the OAG’s retained control in the agreement, the court upheld the trial court’s due process conclusion.

Key Cases Cited

  • Lujan v. Defenders of Wildlife, 504 U.S. 555 (constitutional standing requires actual or imminent injury)
  • Young v. United States ex rel. Vuitton et Fils S.A., 481 U.S. 787 (private counsel in criminal contempt must be as disinterested as public prosecutors)
  • Marshall v. Jerrico, Inc., 446 U.S. 238 (neutrality requirements differ for prosecutorial/plaintiff-like functions)
  • O’Brien v. New Hampshire Democratic Party, 166 N.H. 138 (standing focuses on legal injury law designed to protect)
  • Duncan v. State, 166 N.H. 630 (standing requires an actual, not hypothetical, dispute capable of judicial redress)
  • Berry v. Watchtower Bible & Tract Soc., 152 N.H. 407 (statute does not imply private right of action)
  • Cross v. Brown, 148 N.H. 485 (statutory right does not necessarily create private cause of action)
  • Gallo v. Traina, 166 N.H. 737 (appellant bears burden to demonstrate reversible error)
Read the full case

Case Details

Case Name: State v. Actavis Pharma, Inc. & a.
Court Name: Supreme Court of New Hampshire
Date Published: Jun 30, 2017
Citation: 167 A.3d 1277
Docket Number: 2016-0199.
Court Abbreviation: N.H.